Kelun-Biotech Announces Phase II Results for KH607 in Major Depressive Disorder Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has reported topline results from its Phase II clinical trial evaluating KH607, a novel …
Tag: